Denali Therapeutics Inc.
PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS
Last updated:
Abstract:
The present disclosure relates to methods of making LRRK2-inhibiting, pyrimidinyl-4-aminopyrazole compounds and intermediates of formulae I and IV: The compounds are useful as LRRK2 inhibitors in the treatment of LRRK2 mediated diseases, and as intermediates for their manufacture. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
19 Dec 2018
Issue date:
14 Jan 2021